Dimensional Fund Advisors
GYRE icon

Dimensional Fund Advisors’s Gyre Therapeutics GYRE Stock Holding History

Dimensional Fund Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$176K Buy
25,268
+14,365
+132% +$112K ﹤0.01% 3078
2025
Q4 		$77K Buy
+10,903
New +$84.1K ﹤0.01% 3178
2022
Q2 		– Sell
-10,284
Closed -$51K – 3495
2022
Q1 		$51K Sell
10,284
-55,409
-84% -$275K ﹤0.01% 3462
2021
Q4 		$450K Sell
65,693
-41,166
-39% -$704K ﹤0.01% 3189
2021
Q3 		$3.29M Sell
106,859
-16,568
-13% -$545K ﹤0.01% 2699
2021
Q2 		$4.01M Buy
123,427
+2,414
+2% +$82.8K ﹤0.01% 2669
2021
Q1 		$4.57M Buy
121,013
+15,657
+15% +$716K ﹤0.01% 2615
2020
Q4 		$4.99M Buy
105,356
+1,384
+1% +$59.9K ﹤0.01% 2524
2020
Q3 		$3.35M Buy
103,972
+2,765
+3% +$108K ﹤0.01% 2582
2020
Q2 		$4.46M Sell
101,207
-510
-0.5% -$23.9K ﹤0.01% 2513
2020
Q1 		$3.33M Buy
101,717
+4,352
+4% +$200K ﹤0.01% 2549
2019
Q4 		$4.97M Sell
97,365
-1,674
-2% -$70.1K ﹤0.01% 2613
2019
Q3 		$3.65M Buy
99,039
+2,523
+3% +$136K ﹤0.01% 2702
2019
Q2 		$5.33M Buy
96,516
+7,806
+9% +$488K ﹤0.01% 2617
2019
Q1 		$5.4M Buy
88,710
+20,946
+31% +$1.35M ﹤0.01% 2624
2018
Q4 		$4.01M Buy
67,764
+13,850
+26% +$1.02M ﹤0.01% 2673
2018
Q3 		$4.36M Buy
53,914
+32,360
+150% +$2.56M ﹤0.01% 2718
2018
Q2 		$1.89M Sell
21,554
-1,941
-8% -$340K ﹤0.01% 2900
2018
Q1 		$4.55M Hold
23,495
– – ﹤0.01% 2667
2017
Q4 		$2.4M Buy
23,495
+354
+2% +$18.1K ﹤0.01% 2825
2017
Q3 		$873K Buy
23,141
+12,479
+117% +$374K ﹤0.01% 3019
2017
Q2 		$372K Buy
+10,662
New +$383K ﹤0.01% 3132
2016
Q4 		– Sell
-526
Closed -$72K – 3293
2016
Q3 		$72K Sell
526
-24
-4% -$3.62K ﹤0.01% 3243
2016
Q2 		$94K Sell
550
-41
-7% -$6.99K ﹤0.01% 3240
2016
Q1 		$112K Sell
591
-5
-0.8% -$1.21K ﹤0.01% 3227
2015
Q4 		$210K Sell
596
-1
-0.2% -$393 ﹤0.01% 3209
2015
Q3 		$313K Sell
597
-4
-0.7% -$6.1K ﹤0.01% 3190
2015
Q2 		$1.32M Buy
601
+30
+5% +$60.1K ﹤0.01% 2955
2015
Q1 		$1.34M Sell
571
-15
-3% -$31K ﹤0.01% 2920
2014
Q4 		$1.21M Sell
586
-87
-13% -$168K ﹤0.01% 2968
2014
Q3 		$1.34M Sell
673
-31
-4% -$76.6K ﹤0.01% 2943
2014
Q2 		$2.5M Buy
704
+22
+3% +$71.8K ﹤0.01% 2792
2014
Q1 		$2.55M Sell
682
-22
-3% -$81.4K ﹤0.01% 2778
2013
Q4 		$2.3M Buy
704
+101
+17% +$398K ﹤0.01% 2817
2013
Q3 		$2.52M Buy
603
+179
+42% +$720K ﹤0.01% 2790
2013
Q2 		$1.43M Buy
+424
New +$1.61M ﹤0.01% 2925

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors's GYRE Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Gyre Therapeutics (GYRE) stake by 132% in Q1 2026, buying an estimated $112K and bringing the position to 25,268 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #3078.

Dimensional Fund Advisors first reported a position in GYRE in Q2 2013 and has held it in 36 quarters since. The position peaked at $5.4M in Q1 2019. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Dimensional Fund Advisors held 25,268 shares of Gyre Therapeutics worth $176K as of Q1 2026.
  • Dimensional Fund Advisors bought 14,365 Gyre Therapeutics shares in Q1 2026, an estimated $112K.
  • Gyre Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3078 holding.
  • Dimensional Fund Advisors first reported a position in Gyre Therapeutics in Q2 2013 and has held it in 36 quarters since.
  • Dimensional Fund Advisors's Gyre Therapeutics position peaked at $5.4M in Q1 2019.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.